Kira to Make a Splash at the 41st Annual J.P. Morgan Healthcare Conference

Kira Pharmaceuticals, a biotechnology leader in cutting-edge complement therapies to treat immune-mediated diseases, is proud to announce that Frederick Beddingfield M.D., Ph.D., Chief Executive Officer, will be speaking at the highly respected 41st Annual J.P. Morgan Healthcare Conference. Dr. Beddingfield will deliver the keynote address at 9:00 AM PT on Thursday, January 12, 2023. Don’t miss this incredible opportunity to hear from one of the world’s leading innovators in biotechnology!

On Friday, January 6, 2023, Dr. Beddingfield will join other healthcare leaders in a panel discussion on “Cross-Border Collaboration” at the Longwood Healthcare Leaders Pre-JPM Webconference. This presentation comes in advance of the J.P. Morgan presentation and provides an opportunity to explore strategies for successful international partnerships in healthcare.

About Kira Pharmaceuticals

Kira Pharmaceuticals is changing the landscape of immune-mediated diseases. With its groundbreaking LOGIC platform, the company has developed an impressive pipeline of novel therapies targeting the complement system. Based in Cambridge, Massachusetts, with additional facilities in China and Australia, Kira Pharmaceuticals has assembled a passionate team dedicated to bringing life-altering therapies to people everywhere.

About Longwood Healthcare Leaders:

At Longwood Healthcare Leaders meetings, top minds in biotech, pharma, academia, and life science investing come together to share insights and promote collaboration in the pursuit of translating discoveries into medicines for patients in need. Not only do these meetings provide a platform for meaningful discussion, but they also raise donations for charities.

Leave a Comment